15.1 C
New York
Friday, September 29, 2023

Is CVS Health Corporation (NYSE: CVS) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for CVS Health Corporation (CVS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.16, or 0.23%, to $70.68. The CVS Health Corporation has recorded 277,285 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that CVS Health announces additional responsibilities for executive leadership team members.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

CVS belongs to the Healthcare sector of the NYSE while operating in the Healthcare Plans industry. At the end of the last regular session, the stock closed at $70.52 and fluctuated between $70.92 as its day high and $68.83 as its day low. The current market capitalization of CVS Health Corporation is $90.25B. A total of 13.5 million shares were traded on the day, compared to an average of 9.55M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, CVS has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 25,759 shares. Over the last 12 months, there were 19 BUYs and 19 SELLs from insiders. Insiders purchased 638,615 shares during that period but sold 676,247.

In the most recent transaction, Clark James David sold 25,759 shares of CVS for 74.92 per share on Aug 03. After the transaction, the SVP, Cont & Chief Acct Officer now owns 4,698 company shares. In a previous transaction on May 03, Lynch Karen S bought 14,000 shares at 69.75 per share. CVS shares that President and CEO owns now total 431,392.

Among the insiders who sold shares, Moriarty Thomas M disposed of 137,466 shares on Dec 15 at a per-share price of $98.36. This resulted in the EVP & General Counsel holding 608,129 shares of CVS after the transaction.


Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. CVS Health Corporation pays an annual dividend of $2.42, resulting in a dividend yield of 3.43%, and it has a price to earnings (P/E) ratio of 30.96. CVS’s most recent ex-dividend date was 7/20/2023 when it declared a $0.6050 quarterly dividend that was paid in cash on 8/1/2023. Previously, the company paid the dividend on 5/1/2023 with an ex-dividend date of 4/20/2023. The CVS stock dividend was $0.6050 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for CVS in the last 3 months, the mean price target is $91.47 with high estimates of $110.00 and low estimates of $76.00. In terms of 52-week highs and lows, CVS has a high of $104.83 and a low of $64.62.

As of this writing, CVS has an earnings estimate of $2.13 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $2.21 per share and a lower estimate of $2.01. The company reported an EPS of $2.2 in the last quarter, which was 5.30% higher than expectations of $2.09.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CVS’s latest balance sheet shows that the firm has $12.53B in Cash & Short Term Investments as of fiscal 2021. There were $76.00B in debt and $67.81B in liabilities at the time. Its Book Value Per Share was $56.68, while its Total Shareholder’s Equity was $75.38B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CVS is Buy with a score of 4.25.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles